imatinib mesylate has been researched along with Infarction, Middle Cerebral Artery in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Andrae, J; Betsholtz, C; Dang, ST; Enomoto, A; Fujikawa, M; Fujimori, T; Hamashima, T; Ishii, Y; Maki, T; Mori, H; Nguyen, HN; Nguyen, QL; Nguyen, VT; Okuno, N; Sasahara, M; Takao, K; Yamamoto, S | 1 |
| Kassner, A; Leung, J; Merali, Z; Mikulis, D; Silver, F | 1 |
2 other study(ies) available for imatinib mesylate and Infarction, Middle Cerebral Artery
| Article | Year |
|---|---|
Vascular PDGFR-alpha protects against BBB dysfunction after stroke in mice.
Topics: Animals; Blood Vessels; Blood-Brain Barrier; Collagen Type I; Hemorrhage; Imatinib Mesylate; Immunoglobulin G; Infarction, Middle Cerebral Artery; Ischemic Stroke; Matrix Metalloproteinase 9; Mice, Knockout; Receptor, Platelet-Derived Growth Factor alpha; Stroke; Transforming Growth Factor beta1 | 2021 |
Longitudinal assessment of imatinib's effect on the blood-brain barrier after ischemia/reperfusion injury with permeability MRI.
Topics: Animals; Benzamides; Blood-Brain Barrier; Brain Ischemia; Imatinib Mesylate; Infarction, Middle Cerebral Artery; Longitudinal Studies; Magnetic Resonance Imaging; Male; Neutrophil Infiltration; NF-kappa B; Permeability; Piperazines; Pyrimidines; Rats; Rats, Sprague-Dawley; Reperfusion Injury; Stroke; Zonula Occludens-1 Protein | 2015 |